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Abstract. It is well known that efficacy of immune functions declines with age. It results in an
increase of severity and duration of respiratory infections and also in dramatic growth of risk of
death due to these diseases after age 65. The goal of this work is to describe and investigate the
mechanism underlying the age pattern of the mortality rate caused by infectious diseases and
to determine the cause-specific hazard rate as a function of immune system characteristics. For
these purposes we develop a three-compartment model explaining observed risk-of-death. The
model incorporates up-to-date knowledge about cellular mechanisms of aging, disease dynamics,
population heterogeneity in resistance to infections, and intrinsic aging rate. The results of
modeling show that the age-trajectory of mortality caused by respiratory infections may be
explained by the value of antigenic load, frequency of infections and the rate of aging of the
stem cell population (i.e. the population of T-lymphocyte progenitor cells). The deceleration of
infection-induced mortality at advanced age can be explained by selection of individuals with a
slower rate of stem cell aging. Parameter estimates derived from fitting mortality data indicate
that infection burden was monotonically decreasing during the twentieth century, and changes
in total antigenic load were gender-specific: it experienced periodic fluctuations in males and
increased approximately two-fold in females.
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1. Introduction
Aging of the immune system, as well as aging of the entire organism, occurs at all levels of its hierarchy.
It occurs at the level of cells – the telomeres of T cells shorten with age, which results in a decrease in
immune reaction rates. At the level of cell population – a decrease in the number of na¨ıve T cells and
an increase in the number of T memory cells take place. At the level of the whole immune system -
the volume of the peripheral lymphoid tissue shrinks with increasing age. All these processes lead to a
decrease in the immune function efficacy and an increase in the frequency and the severity of infections,
and an increase in the chances of death from infectious diseases with age.
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Immunosenescence may contribute to development of many other health disorders. Zhu et al revealed
that viral and bacterial infections could have an influence on development of cardiovascular diseases
[43, 44]. The authors found that increasing pathogen burden is significantly associated with increasing
risk of coronary artery disease and myocardial infarction. Cawthon et al found that deaths from heart
disease were significantly more frequent in patients with short telomere lengths of blood cells’ DNA than
in those with long telomere lengths [8]. These indicate that aging of immune system may be associated
not only with increased proportion of deaths from infectious diseases among the elderly, but also with
other major causes of death in developed countries [6, 17].
A study of the immune system of healthy centenarians [13, 34] revealed that several immune parame-
ters of these individuals were well conserved and close to normal values for age 50. There exists a great
deal of evidence that the rate of immunosenescence can vary widely [35]. The sources of such variation
have genetic and environmental origin, however neither factors nor mechanisms of regulating immunose-
nescence are exactly known. One can suspect an important role of antigenic load, first in development,
and then in deterioration of the immune system during the life course [14, 25, 28, 29]. The evidence is
accumulating that chronic and acute diseases could accelerate immunosenescence [30, 35, 41]. Modifica-
tion of the immune state using vaccination, antiviral and hormonal therapies, stem cell transplantation
– and possibly by regulation of telomerase activity [2, 11] – could slow down processes associated with
immunosenescence. Results of such interventions are determined by several processes, among which the
processes maintaining long-term homeostasis of lymphocyte concentration play a crucial role. During
immune response to infection, the population of specific lymphocytes rapidly grows and increases by 5-6
orders of magnitude. After pathogen elimination, 95-99% of the specific lymphocytes die within 10-20
days; the rest survive and replenish the pool of memory cells. The capacity of the immune system to
support the population of T lymphocytes is suggested to be limited by the volume of peripheral lymphoid
tissue; therefore newly produced memory cells accelerate death of existing memory cells. Vaccinations
and application of immunostimulators contribute to this effect. High activity of the thymus also reduces
the duration of protective immunity since new na¨ıve cells crowd out memory cells [15].
Process of pathogen transmission within a population is traditionally considered by epidemiologists [16,
19, 26, 42]. Host’s resistance is an important epidemiological factors and its changes are determined by
efficacy of host immune system. Therefore, it is important to examine the impact of immunosenescence
on epidemiology of respiratory infections and related mortality.
In this paper we assume that an increase in the mortality from infectious diseases in human cohorts
with age is associated with the aging related decline in immune system functioning, and investigate the
mechanisms underlying the relation between the risk of death from respiratory infections and immunose-
nescence. For this purpose we developed a model of immunosenescence and its connection to the risk of
death from respiratory infections (MIRD). We use this model to fit data on deaths caused by bronchitis,
pneumonia and influenza for Italian cohorts born between 1873 and 1895 [5]. As a result we obtain and
interpret the time trajectories of indices describing changes in antigenic load, frequency of infections, rate
of telomere erosion in T-lymphocyte progenitor cells in different ages.
2. Model of immunosenescence and risk of death from respiratory infections
(MIRD)
The MIRD consists of three compartments (Fig. 1). The first compartment is a model of immunose-
nescence. It describes age related changes in immune system characteristics. The second model makes
it possible to estimate the severity of infectious disease for different states of the immune system. The
state of the immune system is determined by the concentration and replicative capacity of naive and
memory T cells. These properties determine the rate of immune response to infection. The third com-
partment of MIRD is a function describing population heterogeneity in resistance to infections. Multiplied
by the frequency of respiratory infections, it yields the estimated risk of death from the diseases in the
population.
2.1. Model of immunosenescence
The mathematical model of immunosenescence [31, 32] describes age-related changes in a population of
peripheral T cells. These changes could be subdivided into two groups – determined by genetic and
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Figure 1. Flow chart of the mathematical model of immunosenescence and risk of death
from respiratory infections (MIRD).
environmental factors. The former group contains shortening of telomere length in stem cells, thymus
involution and diminishing of the peripheral lymphatic tissue. The rates of the processes are presumed
to be intrinsic (heritable) properties of the individuals.
The following processes form the latter group
– a decrease in the concentration of na¨ıve T cells in the intact peripheral lymphoid tissue (N(τ));
– an increase in the concentration of memory T cells (M(τ)); and
– a shortening of the length of DNA telomeres in naive and memory T cells (PN (τ) and PM (τ), respec-
tively).
Their rates depend on antigenic load, which includes both infectious and noninfectious antigens. The
model of immunosenescence is a system of nonlinear differential equations:
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The first equation describes changes in the concentration of the na¨ıve T cells with age (τ). The first term
characterizes the influx of na¨ıve T cells from the thymus. Since the volume of functioning tissue in thymus,
which determining level of N∗ might decrease to the undetectable level without serious consequences for
the health [37] we can describe the age dynamics of the rate of na¨ıve T cells influx as
N∗(t) = N∗0 e
−kT t. (0.5)
Under the action of antigenic load, the number of na¨ıve T cells decreases (the second term), and the
number of memory T cells increases (the first term of the second equation). The antigenic stimulation
also causes proliferation of memory T cells, which is described by the second term of the second equation.
Here L characterizes antigenic load. It is supposed to be constant during the lifetime. In the context of
the model, the value of antigenic load determines rates of consumption of na¨ıve T cells and expansion of
memory cells.
The third equation describes the dynamics of average telomere length PN in na¨ıve T cells. Here P
∗ is
the telomere length in cells that have recently left the thymus. The length of telomere in new na¨ıve T
cells cannot be less then Heyflick limit, Pmin, so it decreases with age as
P ∗(t) = (P ∗0 − Pmin)e−kP t + Pmin. (0.6)
The last equation describes the changes in average telomere length in memory T cells. The rate of
this process is determined primarily by the difference between average length of telomere in na¨ıve and
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Figure 2. Infection-induced damage of tissues in the course of disease for different ages.
On the vertical axis – the fraction of destroyed cells in target organ. Disease severity is
defined as a maximum of tissue damages [24].
memory cells minus the average telomere loss during immune response. It is also proportional to the
antigenic load.
The volume of the intact peripheral lymphoid tissue decreases with age as
V (t) = (V0 − Vmin)e−kV t + Vmin (0.7)
and compensates for the decline of the total number of T cells.
The parameters values and initial conditions for the system (0.1-0.7) are given in Appendix 1.
2.2. Model of infectious disease
This mathematical model describes the processes that determine beginning, course and outcome of any
infection: invasion and propagation of the pathogen, infection-induced damage of tissues, immune re-
sponse, elimination of the pathogen and tissue regeneration [22]. Model parameters are the rates of these
processes. The values of the parameters determine severity and outcome of the modeled disease. Hence,
age-related changes in disease severity (and therefore the risk of lethal outcome) can be evaluated as a
result of the varying rate of immune response according to the age trend.
In Fig. 2 the extent of tissue damage in the course of disease is presented for different ages. Disease
severity is defined by a maximum of tissue damage. The higher the disease severity is, the higher the risk
of lethal outcome. Detailed description of the model’s equations, variables and parameters are given in
Appendix 2.
2.3. Relationship between disease severity and the risk of death
The conjunction of the model of immunosenescence (0.1-0.7) and the model of infectious disease (0.9-
0.12) allows us to model the age related increase in the disease severity for an average individual. In
order to execute the transition to the population level we should take into consideration the fact that
the individual probability of death from respiratory infection at age τ depends on probability of getting
infected (pinf ) and probability of death from certain tissue damage (pL). pinf and pL are supposed to
be i.i.d. and therefore, the required probability of death from respiratory infections can be defined as
a product of pinf and pL. The probability of getting infected is supposed to be a characteristic of the
environment and might vary with time and location [33]. So, this parameter is calculated while the data
on the cohort mortality are fitted. The probability of death having certain volume of damaged tissues
was determined on the base of the clinical study [23]. Having analyzed 600 cases of acute pneumonia the
authors concluded that 4% of the patient died when only 10% of the lung tissues were destroyed and a
half of the patients survives if the pneumonia attacked 35% of lung tissue. Hence, the probability of death
at the volume of damaged tissues m can be defined as a cumulative distribution function with mean value
4
✐✐
“mmnpSannicova” — 2017/8/6 — 23:35 — page 5 — #5
✐
✐
✐
✐
✐
✐
T. E. Sannikova, A. A. Romanyukha, E. Barbi, G. Caselli, C. Franceschi, A. I. Yashin immunosenescence and risk of death
P
*
,
[b
.p
.]
20 40 60 80 100
5000
6000
7000
8000
E
0
Age, [years]
Figure 3. The average length of the telomeres calculated among alive individuals can
increase since the selection favored those with slow rate of aging (hypothetical plot). P ∗
is the telomere length in the progenitor of na¨ıve cells. The upper dotted line shows the
telomere length in the subpopulation with slow immune system aging. The lowest dotted
line corresponds to the fast aging subpopulation. The solid line describes the changes
of average telomere length in the progenitor of na¨ıve cells of the whole population. It is
supposed that after age equal to the life expectancy at birth (E0) the cohort consists of
the individuals with low rate of telomere shortening.
m = 0, 35.
pL(m) = Φ(m) =
∫ m
0
1
σ
√
2pi
e(t−a)
2
dt. (0.8)
The values of the parameter were estimated based on clinical observations [23].
Thus, by means of the model of infectious disease and expression (0.8), the relationship between
immunosenescence and risk of death could be established.
2.4. Mortality from respiratory infections in the heterogeneous population
It is a well-known fact that it is quite difficult to get a numerical estimate of immune defense efficiency
but indirect evidence such as data on mortality from respiratory infections might be received. The left
panel of Fig. 4 represents shaded contour maps of age-specific probabilities of death from respiratory
infections for 23 male and 23 female cohorts born between 1873 and 1895 in the range of age from 50
to 98. The maps offer a panoramic view of the male and female evolution of mortality over cohorts. The
shading goes from white to black as the surfaces rise from low to high mortality. These cohorts faced
the most dramatic events in history: wars, introduction of antiseptics and antibiotics, industrialization
and urbanization. The difference in life expectancy at birth between the former and the latter cohort is
more than 10 years [7]. Therefore it can be concluded that the earlier cohorts experienced more selection
pressure than the later ones. As it was shown in [38] the selection might influence the shape of curve of
cohort characteristics in different way. For the sake of accuracy the selection in the heterogeneous cohort
should be taken into account.
Analysis of the mathematical model of immunosenescence (0.1-0.7) revealed that the strength of im-
munity at advanced age strongly depends on the rate of telomere erosion in T-lymphocyte progenitor
cells accumulated during the life course. The telomere length in the progenitor of naive cells was assumed
to be prone to the pressuer of the selection. For example, it was shown that individuals with shorter
telomere lengths had a higher all-cause mortality rate, as well as a higher mortality rate from infectious
diseases [8]. Hence, it is reasonable to assume that deceleration of mortality rates at old ages is related
(attributable) to the selection of individuals with slower rates of telomere shortening in stem cells. It is
then that the average rate of telomere erosion in T-lymphocyte progenitor cells in the cohort is supposed
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to decelerate. This hypothesis was tested using data on mortality rates from respiratory infections in
Italian cohorts born between 1873 and 1895.
Simulation of MIRD is a sequence of numerical calculation of each part of the model. First of all, the
set of equations (0.1)-(0.7) describing the process of immunosenescence is solved by using Matlab solver
for non-linear differential equation. The parameters values and initial values of the variables can be found
in the table 1 (Appendix 1).
Secondly, for ages τ = 20, 21...98 the course of respiratory disease is simulated by means of the model
(0.9)-(0.12) (Appendix 2) with the parameter values given in Table 2.. The initial value of the variable
describing the concentration of immune cells is defined by the numerical decision of the previous model
as far as the rate of their proliferation (see formula (0.14), (0.15)). The greatest value of the variable
mC representing the fraction of damaged tissues gives us the severity of the disease for age τ . It should
be noticed that the system of differential equations (0.9)-(0.12) is solved by Matlab procedure for stiff
problems.
Thirdly, using the function of probability of death for each severity and multipling it by probability of
getting infected (pinf ) the probability of death from respiratory infection at age τ is calculated.
Let us assume that the population cohorts can be divided into two sub-cohorts: with slow and fast
rates of immune system aging represented by the rate of decline of average telomere length in respective
sub-cohort. Then the rate of immune system aging of the entire cohort before age of E0 is equal to the
population average. Because of mortality selection process those with shorter telomeres (sub-cohort with
fast rate of aging of immune system) will die first. Therefore the average age trajectory of the telomere
lengths in T-lymphocyte progenitor cells will show decelerated rate of decline in telomere length (Fig. 3).
In the model (0.1-0.7), the decrease in telomere length in the progenitors of na¨ıve cells is described
by expression (0.6), where kp is the average rate of aging in population. Then age-related changes in the
rate of telomere shortening in the progenitors of na¨ıve cells kp related to the population heterogeneity
could be specified by the following formula
kp(τ) =
kp1 + kp2
2
− kp1 − kp2
2
· e
v(τ−E0) − e−v(τ−E0)
ev(τ−E0) + e−v(τ−E0)
,
where kp1 is the mean rate of telomere shortening in the progenitors of na¨ıve cells in the initial population
and kp2 is the mean rate in the long-lived population.
3. Results
We fit the life-table data on probability of death caused by respiratory infectious for male and female
Italian cohorts born between 1873 and 1895. There is good agreement between the model and the data
sets for medium and large values of the death rate (Fig. 4). In the case of small values (less then 0.005),
the estimated risk of death is higher then observed. To provide a good fit, four parameters of the model
were estimated for every cohort: two characteristics related to the environment (antigenic load and the
frequency of respiratory infections) and heritable characteristics (the rates of telomere shortening in stem
cells).
It can be seen (Fig. 5a) that antigenic load for males did not change much during this period of time.
In females the antigenic load in 1873 was lower than that in males and increased with the year of birth
of the cohort. The frequency of respiratory infections declines with year of birth for both sexes (Fig. 5b).
Note that the data show that progress in reduction of male mortality from infections is slower than that
of females. This observation is in agreement with slower progress in reduction of total mortality in males
compared to females [40]. Here faster progress in reducing female mortality is reflected by faster decline
in the frequency of respiratory infections in females.
Estimated rates of telomere erosion in T-lymphocyte progenitor cells are represented in Fig. 6. Fig. 6a
shows the average rate of aging at young and middle ages for male and female cohorts. The estimated
rates of stem cell aging in old age for men and women are shown in Fig. 6b. One can see that the rate of
aging in old age is approximately five times less than in young and middle ages. In our opinion, this can
be a consequence of greater probability of death among individuals with higher rates of stem cell aging.
Analysis of the trends reveals that female cohorts experienced a constant decrease in the rate of stem
cell aging at young and middle ages – and an increase of the rate of aging in old age. This rearrangement
(alteration) is probably accounted for by the significant increase in life expectancy (life span): from 46 to
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Figure 4. Shaded contour maps [39] of age-specific probabilities of death caused by
bronchitis, pneumonia and influenza for Italian cohorts born between 1873 and 1895.
Comparison between model(right panel) and data(left panel). Calendar year is located
on horizontal axis and the age – on the vertical axis.
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Figure 6. Estimated rates of telomere erosion in T-lymphocyte progenitor cells in Italian
cohorts born between 1873 and 1895: a) in young and middle age, b) in old age.
55 years. An additional factor that decelerates aging of T-lymphocyte progenitor cells could be a decrease
in frequency of infections (Fig. 5b). Then the increase in the rate of stem cell aging in the older group is
caused by inflow of large numbers of individuals with relatively higher rates of aging.
It is interesting that we found no such pattern in male cohorts: the frequency of infections decreased
to a lesser extent and experienced fluctuations; changes in the rates of stem cell aging showed no trend.
4. Discussion
The proposed model describes the relation between physiological and demographic aging. There is some
evidence that replicative senescence of T cells results in growth of mortality caused by respiratory infec-
tions [1, 10, 27]. Clinical and experimental data show that exhaustion of T cell immunity is responsible
for an age-related increase in severity and duration of viral infections. Severe viral infections at advanced
age often induce severe and fatal bacterial infections, since replicative senescence of T cells is strongly
associated with mortality from bacterial infections.
According to the proposed model, disease severity is determined by the concentrations of T cells and
by the length of their DNA telomeres. After age 60, the course and outcome of infectious disease are
highly influenced by the length of T cell telomeres. The existence of an association between higher risk
of death from infectious disease and shorter telomere length was shown [8]. This association is masked
by the genetically determined diversity of telomere length in the population. As shown in a twin study,
[36] the heritability of telomere length accounts for 78%; the other 22% is attributable to environmental
factors. At the same time, there is some evidence that heritability of lifespan does not exceed 35% [18,21].
The proposed model is an attempt to comprehend the roles of genetics, individual immune history and
environment in longevity.
In our model environmental pressure on the immune system is characterized by the parameter of
antigenic load which includes infectious load and intake of non-infectious antigens contained in food
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and air. The infectious load includes acute and chronic infections and can be defined as a mean rate of
pathogen invasion in the organism. The value of this parameter characterizes the efficiency of immune
defense in coping with infectious contamination.
As mentioned above, the antigenic load did not change much in males (Fig. 5a). In female cohorts
born before 1879 the antigenic load was almost constant and 2.5 times less than that in male cohorts.
For female cohorts born after 1879 the value of this parameter increased with year of birth, in other
words the antigenic load is higher in those cohorts who were 19-35 years old in 1915. Italy, during the
Great War (1915-1918), was still a very poor and culturally backward country. The industrial revolution
did not take off until the beginning of the new century and was mainly limited to the major cities in
the Northwest and the surrounding areas. Agriculture was still the main activity throughout the country
and women, when the men left for the front, had to take on the extra burden of the hard labour in the
fields and cover the industrial occupations abandoned by their men in order to support as well as care
for their numerous offspring. Families at the time were numerous, social and health structures almost
non-existent, public hygiene and in the home extremely lacking and nutrition poor. Women found it hard
to reconcile their domestic chores with work outside the house, often paid at bare subsistence levels. The
effects of poverty and malnutrition caused mortality levels that mirrored those of the ancient regime,
both for women and for children. Indeed, the number of women at home who died more or less equalled
that of the men who were at war and they were particularly struck by the Spanish flu epidemic, being
more frail and malnourished that the men at the front [3, 4]. Since this process was accompanied by a
decrease in frequency of infections (Fig. 5b) it can be suggested that infectious load was increasing due
to growth of incidences of chronic diseases.
The rate of telomere erosion in stem cells is an important biological characteristic determining life
span of an individual. It is determined both by genetics and life history [9, 12, 20, 36]. For females the
rate of stem cell aging in young and middle ages was decreasing with year of birth (Fig. 6a), for males
this characteristic was decreasing for cohorts born between 1873 and 1884 and increasing for almost all
cohorts born between 1885 and 1895. A female organism is designed for child-bearing and it is natural
to assume that this process is accompanied by excessive load on stem cells and accelerated shortening of
their telomeres. Greater growth of the life expectancy in females compared to males could be caused by
the decrease of the rate of stem cell aging which was due to significant changes in life style that affected
child-bearing function and its realization (number of pregnancies and deliveries).
The proposed model establishes the relationship between physiological adaptation to antigenic load and
age-specific mortality from infectious diseases. The approach developed allows for estimation of individual
risk of death caused by infection and analysis of the impact of the environment on immunosenescence.
0.1. Appendix 1.
0.2. Appendix 2. Model of infectious disease
This mathematical model describes [22] the processes which determine beginning, course and outcome
of all infections: invasion and propagation of the pathogen, infection-induced damage of tissues, immune
response, elimination of the pathogen and tissue regeneration. Variables of the model are
K(t), the concentration of the pathogen in target tissue;
C(t), the concentration of specific lymphocytes in draining lymph nodes;
F (t), the concentration of specific antibodies in blood;
mc(t), the fraction of target cells destroyed by pathogen.
The dynamics of immune response is described by the system of four differential equations
dK
dt
= βK − γFK, (0.9)
dC
dt
= α(1−mc)FK − µc(C − C∗), (0.10)
dF
dt
= ρC − ηγFK − µfF, (0.11)
dmc
dt
= σ(1−mc)K − µmmc. (0.12)
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Table 1. Initial conditions and model parameters for simulation of the normal aging of
the immune system
Parameter Physical meaning and dimension Estimate
α1 Coefficient of sensitivity of na¨ıve T cells to antigen
load (ml g−1)
1.5 · 104
α2 Coefficient of sensitivity of memory T cells to antigen
load (ml g−1)
1.5 · 104
µN Death rate of na¨ıve T cells in the absence of antigen
load (day−1)
1.8 · 10−4
µM Death rate of memory T cells (day
−1) 0.05
ρ1 Number of memory T cells produced by one na¨ıve cell 100
ρ2 Number of memory T cells produced by one memory
cell
1.1
λN Length of telomere repeats lost during transformation
of na¨ıve cells to memory cell (bp cell−1)
1400
λM Length of telomere repeats lost during self replication
of memory cells (bp cell−1)
500
M∗ Low limit for normal concentration of memory T cells
in lymphoid tissue (cellml−1)
2.5 · 109
kT Rate of diminishing of na¨ıve T cells production with
age (day−1)
1.1 · 10−4
kV Relative rate of reduction of lymphoid tissue volume
with age (day−1)
2.7 · 10−5
kP Relative rate of the telomere repeats reduction in the
progenitor of na¨ıve T cells (bp day−1)
1 · 10−5
L Antigen load (g day−1) 1 · 10−6
N∗0 The rate of T cell production by the thymus at the
age of 18 (cell day−1)
4 · 108
V0 Volume of lymphoid tissue at the age of 18 (ml) 1500
Vmin Minimal volume of lymphoid tissue (ml) 100
P ∗0 Length of telomere repeats in na¨ıve T cells produced
at the age of 18 (bp cell−1)
8.3 · 103
Pmin Minimal length of telomere repeats in the progenitor
of na¨ıve T cells
100
N0 The concentration of na¨ıve T cells at the age of 18
(cellml−1)
1.9 · 109
M0 The concentration of memory T cells at the age of 18
(cellml−1)
6.45 · 108
PN0 Length of telomere repeats in na¨ıve T cells at the age
of 18
8.8 · 103
PM0 Length of telomere repeats in memory T cells at the
age of 18
7.4 · 103
with the following initial conditions
K(t0) = K0; C(t0) = Cm + C
∗; F (t0) =
ρ(Cm + C
∗)
µf
; mc(t0) = 0. (0.13)
Note that the expression for initial value of specific lymphocytes contains the concentrations of na¨ıve
lymphocytes C∗ and memory cells Cm that are specific to the pathogen under consideration. We assume
that the level of specific na¨ıve lymphocytes is homeostatic and in case of natural death of lymphocytes
only the excess (cloned) lymphocytes die (see the last term in eq. 0.10).
The particular feature of the model of infectious disease is an equation for dynamics of target tissue
damage. Wide tissue damage causes loss of homeostasis and reduces lymphocytes proliferation (the first
term in eq. 0.10).
In clinical practice [23] a maximum of tissue damage is interpreted as disease severity S. In case of
pneumonia damage of less than 15% cells of three lower segments of lung corresponds to mild disease
with a low risk of death , damage of 35% cells of three lower segments of lung corresponds to medium
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Table 2. Initial conditions and model parameters for simulation of infectious disease
Parameter Physical meaning and dimension Estimate
β Rate of pathogen propagation (day−1) 0.35
γ Rate of pathogen neutralization by antibodies (ml
pt−1 day−1)
8.5 · 10−14
α Rate of specific lymphocyte proliferation (ml pt−1
day−1)
5 · 10−11
µC Death rate of specific lymphocytes (day
−1) 0.5
ρ Rate of antibody production by lymphocytes (day−1) 7 · 103
η Number of antibodies required to neutralize one
pathogen particle
20
µf Death rate of specific antibodies (day
−1) 0.05
σ Rate of target organ damage by the pathogen (ml
pt−1 day−1)
9 · 10−9
µm Rate of target organ regeneration (day
−1) 0.4
K0 Infecting dose (pt ml
−1) 103
C∗ The concentration of specific na¨ıve lymphocytes (cell
ml−1)
-
Cm The concentration of specific memory cells (cell ml
−1) -
k1 The fraction of na¨ıve T cells involved in immune re-
sponse
1.5 · 10−6
k2 The fraction of memory T cells involved in immune
response
4.3 · 10−4
severity with a death risk of 0.5, disease with greater than 0.45% destroyed target tissue is defined as
severe with a very high probability of death (≥ 0.77).
Varying the rate of immune response and initial concentration of specific lymphocytes according to
the age trend we can simulate the course of infectious disease for different ages. It is assumed that the
concentration of specific lymphocytes at the beginning of the infection depends on current concentrations
of na¨ıve and memory T cells as follows
C(t0, τ) = C
∗(τ) + Cm(τ) = k1N(τ) + k2M(τ), (0.14)
where t0 denotes the time of the beginning of disease, τ denotes the age.
There are a lot of evidence that the rate of lymphocyte proliferation decreases with age. Denote by
α0 the rate of specific lymphocyte proliferation at age of 18 and by α(τ) one at age τ . We assume that
the ratio α(τ)
α0
is equal to the ratio of replicative capacity of T cells involved in immune response at age
τ to one at age of 18. The proliferative capacity of na¨ıve T cells involved in immune response at age τ is
defined by the concentration and the mean length of their telomeres k1N(τ)(PN (τ)−H). Here H is the
Hayflick limit – the cell stops division when telomere becomes shorter than H. The proliferative capacity
of memory T cells can be represented in the similar manner. Then, the expression for α(τ) is as follows
α(τ) = α0
k1N(τ)(PN (τ)−H) + k2M(τ)(PM (τ)−H)
k1N0(P 0N −H) + k2M0(P 0M −H)
, (0.15)
where P 0N , P
0
M , N
0, M0 are values of respective variables for age of 18.
Note that immune processes described in model of immunosenescence and in equation (0.10) are located
in lymph nodes, equation (0.9) represents changes of pathogen concentration in target tissue and equation
(0.11) deals with antibody concentration in the blood. We consider varibles located in different spatial
compartments in order to have a right to use reasonable physical constants for modelling cell interaction.
All transfer rates are comprised in the estimates for the rates of interactions (see for details [24]).
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